Literature DB >> 16382180

Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin.

Sule Karaman1, Joan Cunnick, Kan Wang.   

Abstract

Enterotoxigenic strains of Escherichia coli produce a heat-labile holotoxin (LT), which causes diarrhea. We engineered corn seeds to produce LT-B, the nontoxic subunit of LT, to serve as a plant-derived vaccine to traveler's diarrhea and as an adjuvant for co-administered proteins. We previously demonstrated that a strong mucosal and systemic antibody response is elicited in young mice with oral administration of corn-derived LT-B. The present study examined systemic and mucosal antibody responses to LT-B in young and aged mice, and recall responses to oral administration and injection of LT-B in aged mice. Specific IgA and IgG antibodies were detectable during an 11-mo period, although the concentration of antigen-specific antibodies declined gradually. Booster by feeding or injection dramatically increased the concentration of specific IgA from that seen in young mice. Specific IgG levels were boosted to concentrations similar to those in young mice. This effect may be age-dependent and related to prior immunization exposure. Analysis of the antibody response of naïve aged mice against corn-derived LT-B demonstrated an age-related suppression in specific IgG production, but not specific IgA. These results may provide important information for edible vaccine strategies for young and aged individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16382180     DOI: 10.1385/MB:32:1:031

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  34 in total

1.  The role of thymus in the aging of Th cell subpopulations and age-associated alteration of cytokine production by these cells.

Authors:  C Kurashima; M Utsuyama; M Kasai; S A Ishijima; A Konno; K Hirokawa
Journal:  Int Immunol       Date:  1995-01       Impact factor: 4.823

2.  Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

Authors:  J D Clements; N M Hartzog; F L Lyon
Journal:  Vaccine       Date:  1988-06       Impact factor: 3.641

3.  Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B.

Authors:  T G Lauterslager; D E Florack; T J van der Wal; J W Molthoff; J P Langeveld; D Bosch; W J Boersma; L A Hilgers
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

4.  Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen.

Authors:  T S Kanellos; D K Byarugaba; P H Russell; C R Howard; C D Partidos
Journal:  Immunol Lett       Date:  2000-11-01       Impact factor: 3.685

5.  Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

Authors:  M Pizza; M Domenighini; W Hol; V Giannelli; M R Fontana; M M Giuliani; C Magagnoli; S Peppoloni; R Manetti; R Rappuoli
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

6.  Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.

Authors:  L de Haan; M Holtrop; W R Verweij; E Agsteribbe; J Wilschut
Journal:  Vaccine       Date:  1996-03       Impact factor: 3.641

7.  Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis.

Authors:  Charles Kaplan; Juan C Valdez; Raman Chandrasekaran; Hermann Eibel; Katalin Mikecz; Tibor T Glant; Alison Finnegan
Journal:  Arthritis Res       Date:  2001-10-02

Review 8.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

9.  Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

Authors:  H S Mason; T A Haq; J D Clements; C J Arntzen
Journal:  Vaccine       Date:  1998-08       Impact factor: 3.641

10.  Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.

Authors:  J Xu-Amano; H Kiyono; R J Jackson; H F Staats; K Fujihashi; P D Burrows; C O Elson; S Pillai; J R McGhee
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  5 in total

1.  Sustained expression of human cytomegalovirus glycoprotein B (UL55) in the seeds of homozygous rice plants.

Authors:  Eilleen S Tackaberry; Fiona A Prior; Karen Rowlandson; Monika Tocchi; Jelica Mehic; Suzanne Porter; Mike Walsh; Mark R Schleiss; Peter R Ganz; Ravinder K Sardana; Illimar Altosaar; Anil K Dudani
Journal:  Mol Biotechnol       Date:  2008-04-16       Impact factor: 2.695

2.  Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea.

Authors:  S Karaman; J Cunnick; K Wang
Journal:  Plant Cell Rep       Date:  2011-09-22       Impact factor: 4.570

Review 3.  Corn-based vaccines: current status and prospects.

Authors:  Sergio Rosales-Mendoza; Cristhian Sández-Robledo; Bernardo Bañuelos-Hernández; Carlos Angulo
Journal:  Planta       Date:  2017-03-27       Impact factor: 4.116

4.  Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit.

Authors:  April J Beyer; Kan Wang; Amber N Umble; Jeffrey D Wolt; Joan E Cunnick
Journal:  Environ Health Perspect       Date:  2006-12-19       Impact factor: 9.031

Review 5.  Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.

Authors:  Doreen Manuela Floss; Dieter Falkenburg; Udo Conrad
Journal:  Transgenic Res       Date:  2007-04-14       Impact factor: 2.788

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.